Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxiconazole vs Clotrimazole for Tinea Cruris
NCT07441005Phase 1Completed
- Sponsor
- Hayatabad Medical Complex
- Start
- May 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of oxiconazole in Tinea cruris (TC) (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Assessment of improvement at 6 months. Started May 2025; status: completed.
02
Drugs
oxiconazole
03
Conditions
Tinea cruris (TC)
Beyond the preview
Go deeper on NCT07441005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07441005.